Director, Medical Strategy

Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.

In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).

Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.

What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

As part of our expanding Oncology Medical Affairs team, Corcept is seeking a Director, Medical Strategy. This role will report to the Senior Director, Medical Affairs and will lead medical activities through successful execution of the oncology medical affairs strategy and tactical plan. They will support the clinical development program and commercialization activities in partnership with other key functions across the organization in addition to external partners. They will partner with Commercial, Research and Development, Clinical Development, HEOR and Regulatory Affairs. The Director will leverage advanced medical expertise in partnership with the Medical team on areas spanning external strategy, clinical development, and commercialization. The role provides internal strategy leadership and external ambassadorship for medical science and strategic oncology stakeholders. They will serve as a key member of the Medical Affairs Team contributing to launch & development efforts, maintaining fiscal responsibility, and advancing innovation.

Responsibilities:

• Provide medical leadership and contribute medical/scientific expertise for the development and execution of the Medical Affairs Strategic Plan, objectives, and supportive tactics, including the design of the publication plan
• Monitor competitive landscape and develop strategic deliverables to address emerging needs in evolving treatment landscape
• Collaborate with Clinical Development to design and execute Advisory Boards, ensuring robust physician engagement to inform lifecycle planning, scientific communication, and publication strategy
• Build and maintain strategic partnerships with key medical and scientific experts, academic institutions, and professional societies to inform unmet needs and elevate scientific exchange
• Lead the development of core scientific messaging, speaker training materials, and medical education resources in collaboration with cross-functional teams
• Identify gaps in clinical practice and collaborate cross-functionally to design and implement innovative, data-driven solutions to support patients and healthcare providers.
• Own the strategy and execution of the Integrated Evidence Generation Plan, including the oversight and prioritization of Investigator-Sponsored Research (ISR)
• Establish and track key performance indicators to measure the impact and effectiveness of medical initiatives and continuously optimize plans based on insights
• Uphold Corcept’s Key Principles by driving collaboration, embracing possibilities, following the data, and leading by doing, ensuring all initiatives align with the Company’s ethics and patient-first principles

Preferred Skills, Qualifications and Technical Proficiencies:

• Proven ability to educate, influence, and mentor both internal stakeholders and external thought leaders in clinical, academic, and community oncology settings
• Strong scientific acumen with a demonstrated track record of engaging diverse medical audiences, including research consortia, academic centers, and conference platforms
• Strategic thinker with robust analytical and problem-solving skills; ability to critically evaluate scientific data and translate insights into impactful medical, commercial, or access strategies
• Deep understanding of the U.S. healthcare landscape, pharmaceutical industry dynamics, and clinical as well as health economics practices
• Experience with U.S. medical promotional review processes and regulatory frameworks (e.g., MLR) preferred
• Exceptional written, verbal, and presentation skills, with the ability to distill complex scientific concepts into compelling communications tailored to varied audiences

Preferred Education and Experience:

• Advanced degree in a scientific or medical discipline (PharmD, MD, PhD)
• A minimum of 8-10 industry experience, including at least 4+ years in oncology medical affairs or closely related functions. Prior experience in gynecologic oncology strongly preferred
• Willingness and ability to travel up to 30% for field engagement, conferences, and cross-functional collaboration

The pay range that the Company reasonably expects to pay for this position is $243,300 - $286,300 the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.

 

 

 Applicants must be currently authorized to work in the United States on a full-time basis.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link. 

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

 Please visit our website at: https://www.corcept.com/

Corcept is an Equal Opportunity Employer

Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview.  Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.